Warmest holiday wishes, from all of us at Answer ALS.
A digital holiday card of gratitude. Many thanks and Happy Holidays to all.
Answer ALS Data Sets Featured in GNPC Proteomics Data Challenge on AD Workbench
NEW ORLEANS, November 19, 2025: Alzheimer’s Disease Data Initiative (ADDI) has opened applications for the Global Neurodegeneration Proteomics Consortium (GNPC) Proteomics Data Challenge. Researchers worldwide are invited to analyze the GNPC Harmonized Data Set on the AD Workbench, including Answer ALS cohort datasets. The goal is to accelerate biomarker discovery and improve detection, prognosis, and…
Answer ALS Completes Release of Full Dataset and Integrates ALS TDI ARC Study Data into Neuromine
All data from 1,100+ Answer ALS participants, including ALS TDI’s ARC study data, are now harmonized and accessible via the Neuromine Data Portal, forming the world’s largest open ALS research resource to accelerate discoveries. NEW ORLEANS, November 03, 2025 — Answer ALS today announced the full release of its comprehensive ALS clinical and multi-omics dataset,…
United for Answers: Leading ALS Organizations Announce ‘Champion Insights’ to Unlock Why Athletes and Military Members Face Higher ALS Risk
State-of-the-art remote-participation research seeks to understand how genetic factors linked to intense activities and lipid metabolism may increase ALS susceptibility NEW ORLEANS, August 13, 2025 — Answer ALS, in collaboration with ALS Therapy Development Institute (ALS TDI) and Augie’s Quest, today announced plans to launch Champion Insights, an ambitious research initiative designed to uncover critical…
Answer ALS Launches AI Drug Development Collaboration with GATC Health, Pennington Biomedical Research Center, and Tulane to Advance ALS Treatment Discovery
NEW ORLEANS, July 22, 2025 — Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative aimed at accelerating AI-powered drug discovery for ALS and other neurodegenerative diseases. This effort, known as the Louisiana AI Drug Development Infrastructure for ALS (LADDIA), brings together leading institutions and innovators, including GATC Health — a…
Behind the Mission: The Heartbeat of Answer ALS
Terri Thompson’s Multidisciplinary Approach Terri Thompson didn’t set out to work in ALS research. She had been working on a data-sharing platform for NASA, helping make research from spaceflight experiments easier for scientists to access and use. That experience opened the door to new collaborations, and eventually she was invited to join a group of…
Congress Passes Full-Year Continuing Appropriations Act, Delivering a Devastating Blow to ALS Research
Answer ALS is deeply alarmed and disappointed by Congress’ passage of the Full-Year Continuing Appropriations Act, which includes devastating cuts to ALS research funding. For years, funding for ALS research has grown steadily thanks to bipartisan support and the tireless efforts of the ALS community. These hard-fought increases have fueled groundbreaking progress in understanding ALS,…
Answer ALS and Alzheimer’s Disease Data Initiative Announce Partnership to Connect Neuromine Data Portal and AD Workbench
Integrated data sharing platforms to accelerate research into ALS and Alzheimer’s disease by providing access to collaborative tools and datasets
Answer ALS Releases World’s Largest ALS Patient-Based iPSC and Bio Data Repository
Unprecedented resource, created with Cedars-Sinai, to accelerate ALS research and drive development of targeted therapies globally
ALS Therapy Development Institute, Answer ALS, and Microsoft Announce Groundbreaking Data Sharing Collaboration
The ALS Therapy Development Institute (ALS TDI), Answer ALS, and Microsoft are pleased to announce a collaboration that will bring together the two largest existing clinical and omics data sets relating to ALS. Through this partnership, comprehensive data collected through ALS TDI’s ALS Research Collaborative (ARC) will be added to Neuromine, an innovative data portal…
ANSWER ALS ANNOUNCES DR. JEFFREY KELLER TO LEADERSHIP OF THEIR UNPRECEDENTED OPEN ACCESS ALS DATA REPOSITORY
Dr. Jeffrey Keller to Co-Lead Answer ALS’ Unprecedented Open Access ALS Data Repository. Appointment to Answer ALS bridges revolutionary data repository with renowned biomedical research center. NEW ORLEANS, Louisiana—Answer ALS is excited to announce that Dr. Jeffrey Keller, Ph.D. has been selected as Answer ALS’ Principal Investigator over the program’s renowned open-access data repository, Neuromine….
2023 Year In Review
10 Years of Commitments Met. Ten years ago, Answer ALS didn’t have a name, but the plan was developed to empower researchers around the world to help bring an end to ALS. In the video below, created when the program first began, every commitment made has been or is being met. Through a massive coordination…
Data & Technology
Multi-Omnics Analysis
IPS Cells & Motor Neurons
Clinic & enrollment